ARCHIVES

NCI-Approved Clinical Trials

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

Rituximab Maintenance Improves Survival In Relapse

February 27, 2009

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

Lenalidomide Maintenance Increased PFS and Survival

May 25, 2012

NCAB Members Skeptical On NCI Reorganization; King Has “Alterative;” Terry T Head Centers

January 27, 1978

ACD Honors Sullivan, Who Reaffirms Anti-Smoking Effort

June 29, 1990

Organ Site Program Fate On Line, Gets Review Next Week

November 20, 1981